Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Schemes of Administration of Intravenous Ketamine in Treatment-resistant Depression: Clinical-neuroimaging Correlation

NCT03742557 is registered in ClinicalTrials.gov with National Institute of Neurology and Neurosurgery, Mexico as lead sponsor.

NCT NCT03742557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03742557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Schemes of Administration of Intravenous Ketamine in Treatment-resistant Depression: Clinical-neuroimaging Correlation
Lead sponsor
National Institute of Neurology and Neurosurgery, Mexico
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2018
Completion date
January 1, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression